| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |